Management of Dyslipidemia for Cardiovascular Risk Reduction (Lipids)

Publication Date: June 1, 2020
Last Updated: March 14, 2022

Recommendations

Primary Prevention: Screening and Assessment of Cardiovascular Risk

For primary prevention in patients over age 40 and not on statin therapy who have not developed new cardiovascular risk factors (e.g., diabetes, hypertension, tobacco use), we suggest against offering a cardiovascular disease risk assessment more frequently than every five years.
Weak Recommendation against
6731

Overview

Title

Management of Dyslipidemia for Cardiovascular Risk Reduction (Lipids)

Authoring Organization